Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 118,410 | reported | 16 Apr 2026 | tx 48+384,451−54,149 |
| Inozyme Pharma, Inc. | 56,000 | reported | 03 Oct 2024 | tx 1+56,000 |
| Denali Therapeutics Inc. | 17,901 | reported | 31 May 2024 | tx 6+68,209 |
| Rezolute, Inc. | 12,000 | reported | 19 Nov 2025 | tx 3+93,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 28,895 | 0.00 USD | |
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 49,960 | 0.00 USD | deriv |
| 01 Mar 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 11,643 | 0.00 USD | |
| 02 Mar 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 10,539 | 22.80 USD | |
| 19 Nov 2025 | GRANT_AWARD | Rezolute, Inc. | 21,000 | 0.00 USD | |
| 19 Nov 2025 | GRANT_AWARD | Rezolute, Inc. | 12,000 | 0.00 USD | deriv |
| 25 Mar 2025 | GRANT_AWARD | Rezolute, Inc. | 60,000 | 0.00 USD | deriv |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 18,443 | 0.00 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 16,813 | 0.00 USD | |
| 03 Mar 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 15,103 | 42.10 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 30,246 | 0.00 USD | deriv |
| 03 Oct 2024 | GRANT_AWARD | Inozyme Pharma, Inc. | 56,000 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | Denali Therapeutics Inc. | 5,967 | 0.00 USD | |
| 31 May 2024 | GRANT_AWARD | Denali Therapeutics Inc. | 17,901 | 0.00 USD | deriv |
| 01 Mar 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 4,768 | 53.76 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 957 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 19,400 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 34,200 | 0.00 USD | deriv |
| 05 Sept 2023 | SALE | Ultragenyx Pharmaceutical Inc. | 6,000 | 37.96 USD | |
| 19 Jun 2023 | SALE | Ultragenyx Pharmaceutical Inc. | 305 | 48.20 USD | |
| 01 Jun 2023 | GRANT_AWARD | Denali Therapeutics Inc. | 4,216 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | Denali Therapeutics Inc. | 12,649 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 22,000 | 0.00 USD | |
| 01 Mar 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,663 | 0.00 USD | |
| 01 Mar 2023 | SALE | Ultragenyx Pharmaceutical Inc. | 3,664 | 45.25 USD |